• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Assessment of Innovations in Biochips

  • ID: 1193214
  • March 2009
  • 85 Pages
  • Frost & Sullivan

This research service discusses the assessment of innovations in biochips.

This Frost & Sullivan research service titled Assessment of Innovations in Biochips (Technical Insights) analyzes the economic scenarios for biochip applications and the key driving forces and challenges and provides a comprehensive overview of solutions and technologies being developed in this domain. The study effectively maps the growth path for the biochip industry.

This analysis is available through Frost & Sullivan's Technical Insights program. With this program, clients receive industry-leading market research along with comprehensive, objective information that allows your company to mitigate risk, identify new opportunities, and drive effective strategies for growth. For more information on this custom subscription service, please click here.

Technology Overview

Technological Innovations Break New Ground and Bolster Competitiveness in the Biochip Market

The biochip industry comprises an integration of various platforms, including microarrays, microfluidics, and biosensors, which converge on account of the fundamental principle of economies of scale. The economies READ MORE >

Note: Product cover images may vary from those shown

- 1. Executive Summary Scope and Methodology
- - Scope
- - Methodology
- - Summary of Industry Trends in Biochips
- - Key Technology Trends in the Biochips Space
- - Future Directions for Biochips and Recommendations

- 2. Technology Assessment of Biochips Technology Primer on Biochips
- - Introduction to Biochips
- - Biochips and their Applications
- - Drivers Restraints and Challenges for Biochips
- - Technology Drivers for Biochips
- - Challenges and Restraints for Biochips

- 3. Analyst Insights on Innovations in Biochips Strategic Assessment of the Biochip Industry-I
- - Force Field Analysis of the Biochip Industry--Current Scenario
- - Forcefield Analysis of the Biochip Industry--Improved Scenario
- - Porters Competitive Forces Analysis for the Biochip Industry
- - Value Chain Analysis for the Biochip Industry
- - Strategic Assessment of the Biochip Industry-II
- - SWOT Analysis of the Biochip Industry
- - Economics of Competitive Rivalry and Technology Adoption Curve
- - Current Industry Trends and Strategic Positioning of Participants in the Biochip Industry
- - Valuation of Stocks in the Biotechnology Industry* and the Impact of Recession
- - Principal Technological Developments and Potential for Sustainability
- - Future Directions for the Biochip Industry and Strategic Overview of Biochip Companies
- - Strategy Overview of Biochip Companies
- - Future Directions for Biochip Companies--Technology Roadmap for Biochips

- 4. Patents and Key Industry Participants Patents
- - Industry Patents
- - Academic Patents
- - Key Industry Participants
- - Industry Participants
- - Academic Participants

- 5. Decision Support Database Decision support tables
- - Government R&D Investment in Biotechnology--World (2002 to 2012)
- - Government Percentage R&D Investment in Biotechnology--World (2002 to 2012)
- - Total Healthcare Expenditure--World (2002 to 2012)
- - Venture Capital Investment in Biotechnology--World (2002 to 2012)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


Our Clients

Amgen Inc. Bayer AG Bio-Rad Laboratories, Inc. Beckman Coulter, Inc. Novartis AG Baxter International Inc.